Breaking Federal Operation Targeted Progressive Groups and Labor Unions in Minnesota Kushner to Visit Israel and Egypt Amid Gaza Ceasefire Talks Major League Baseball Returns to Iowa’s Field of Dreams for Special Event Texas AG Intervenes in Surrogate Dispute Over Infant with Heart Defect Seahawks Reportedly Pursue Cornerback Facing Felony Charges

Thursday August 13, 2026

Reporter

Replimune, Inc.

3Articles Published

4Communities Covered

Published Articles

Press Release

Replimune Announces Pricing of $150 Million Underwritten Offering

Aug 10

Press Release

Replimune Announces FDA Accelerated Approval of TUDRIQEVTM in Combination with Nivolumab for Unresectable Advanced Cutaneous Melanoma After Progression on an anti-PD-1 Based Regimen

Aug 6

Press Release

Replimune Announces Favorable Outcome of FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Jul 30